Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has shared an announcement.
WuXi AppTec Co., Ltd. has revised the terms of reference for its Nomination Committee to enhance the governance and appointment processes for directors and senior management. This move aims to optimize board composition and strengthen corporate governance, reflecting the company’s commitment to maintaining high standards in its leadership structure.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$133.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. operates in the pharmaceutical and biotechnology industry, providing comprehensive laboratory and manufacturing services. The company focuses on enabling global healthcare organizations to advance their drug development processes.
Average Trading Volume: 9,084,704
Technical Sentiment Signal: Buy
Current Market Cap: HK$323.9B
See more insights into 2359 stock on TipRanks’ Stock Analysis page.